There were 825 press releases posted in the last 24 hours and 332,033 in the last 365 days.

Contact

Please use this form to send email to PR contact of this press release:
SHINKEI Therapeutics Announces Investigational New Drug Application Submission for MR-201, a Novel Dosage Form for Treatment of Pseudobulbar Affect

TO:



FROM:

Please check your email address!

Please, do not fill this field.

Please, do not change this field.

Please, do not fill if your javascript is turned off.

captcha image